PhEur Reference Standards
Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia
PhEur Reference Standards
Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia. The collection of reference standards used for the implementation of the European Pharmacopoeia now consists of more than 2500 substances or mixtures derived from chemical, biological or herbal origin. Their use extends far beyond the European continent. The online database contains over 2500 reference standards and is updated daily. Search by catalogue code, name, monograph or CAS number to find the standard you need. The EDQM also provides Batch Validity Statements, Safety Data Sheets and leaflets to download.
Download the Catalogue today at:
http://crs.edqm.eu/db/4DCGI/web_catalog_CRS
Search the PhEur Reference Standards Database:
http://crs.edqm.eu/
EDQM, Council of Europe
Website: www.edqm.eu & www.edqm.eu/store
E-mail: orders@edqm.eu
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
